Photo biomodulation for Epilepsy: Research Study

Epilepsy manifests in various forms, from focal seizures originating in one brain area to generalized seizures affecting both hemispheres. Symptoms can include convulsions, staring spells, temporary confusion, or subtle changes in sensation and awareness. Beyond the physical episodes, epilepsy often brings challenges like memory issues, anxiety, depression, sleep disturbances, and social stigma. Causes range from genetic factors and head injuries to infections, strokes, or unknown origins. Traditional treatments center on antiepileptic drugs (AEDs), which aim to stabilize electrical activity but frequently fall short. Many patients develop tolerance, experience intolerable side effects such as drowsiness, weight gain, or mood alterations, or simply do not achieve seizure freedom. For drug-resistant cases, options like surgery, vagus nerve stimulation (VNS), or ketogenic diets are considered, yet these carry risks and are not suitable for everyone. This gap in care has driven interest in non-invasive neuromodulation techniques.

Photobiomodulation, often called low-level light therapy or red light therapy for the brain, uses specific wavelengths of near-infrared light (typically 808–940 nm) delivered through a comfortable headset or cap. Unlike surgical lasers, PBM employs gentle, non-thermal photons that penetrate the scalp and skull to reach brain tissue without causing heat or damage. The primary target is the mitochondria—the powerhouses of cells—specifically the enzyme cytochrome c oxidase. When absorbed, these photons boost mitochondrial function, increasing adenosine triphosphate (ATP) production, reducing oxidative stress, and modulating inflammation. In neurological contexts, this leads to enhanced cellular energy, improved blood flow, neuroprotection, and regulation of neurotransmitters like glutamate and GABA. For epilepsy patients, these mechanisms are particularly relevant because seizures involve energy imbalances, excessive inflammation, and hyperexcitable neurons.

Transcranial photobiomodulation delivers light directly to key brain regions involved in seizure generation and propagation, such as the hippocampus and neocortex. By energizing mitochondria, tPBM helps restore metabolic balance in hyperexcitable neurons, potentially reducing the likelihood of abnormal electrical discharges. Preclinical models demonstrate decreased interictal epileptiform discharges (IEDs), fewer high-frequency ripples associated with seizure onset, and improved synaptic health. Patients at our center often report subtle but meaningful improvements: better sleep, reduced brain fog, enhanced mood stability, and a subjective sense of calmer neurological activity. Because PBM also lowers neuroinflammation and supports neurogenesis, it may address underlying contributors to refractory epilepsy rather than merely suppressing symptoms. Our integrated protocol includes baseline qEEG mapping to identify optimal light placement and dosage, followed by regular monitoring to refine treatment.

Houston Neuroscience Brain Center is actively recruiting participants for our EEG study exploring photobiomodulation’s effects on epilepsy. If you are 18 years or older, live in the greater Houston area, and have a confirmed medical diagnosis of epilepsy, you may qualify. The study combines advanced EEG/qEEG brain mapping with daily transcranial photobiomodulation sessions to evaluate improvements in seizure control, brainwave stability, and overall well-being—at no cost to participants. Study benefits include comprehensive neurological assessments, personalized PBM treatment protocols, expert follow-up with our multidisciplinary team, and the opportunity to contribute to groundbreaking epilepsy research. Sessions are convenient, non-invasive, and conducted in our comfortable Houston clinic. Preliminary data from similar protocols suggest potential reductions in seizure frequency and enhanced quality of life, though results vary by individual.